Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
2018 05 18
Journal Article
Authors:
Jarrett, O.D.;
Seward, J.F.;
Fombah, A.E.;
Lindblad, R.;
Jalloh, M.I.;
El-Khorazaty, J.;
Dawson, P.;
Burton, D.;
Zucker, J.;
Carr, W.;
Bah, M.M.;
Deen, G.F.;
George, P.M.;
James, F.;
Lisk, D.R.;
Pratt, D.;
Russell, J.B.W.;
Sandy, J.D.;
Turay, P.;
Hamel, M.J.;
Schrag, S.J.;
Walker, R.E.;
Samai, M.;
Goldstein, S.T.
Secondary:
J Infect Dis
Volume:
217
Pagination:
S24-S32
Issue:
suppl_1
PMID:
29788346
Keywords:
Adult; Drug-Related Side Effects and Adverse Reactions; Ebola Vaccines; Epidemics; Female; Hemorrhagic Fever, Ebola; Humans; Male; Middle Aged; Sierra Leone; Survival Analysis; Vaccines, Synthetic; Young Adult
Abstract:
Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].
